Firefighter Willingness to Participate in a Stem Cell Clinical Trial for Burns: A Mixed Methods Study
Authors
Affiliations
Methods: A sequential explanatory mixed methods design was used. The quantitative phase (online questionnaire) was followed by the qualitative phase (semi-structured interviews). A sample of 149 firefighters completed the online survey, and a purposeful sample of 15 firefighters was interviewed.
Results: A majority (74%) reported they would participate in a future stem cell clinical trial if they experienced burn benefiting from STSG. Hypothetical concerns related to receiving a STSG were pain, itch, scarring/redness and skin durability. Participants indicated willingness to undergo stem cell therapy if the risk of no improvement was 43% or less. Risk tolerance was predicted by perceived social support and having children. Interviews revealed four main themes: a desire to help others, improving clinical outcomes, trusting relationships, and a belief in scientific investigation. Many participants admitted lacking sufficient knowledge to make an informed decision regarding stem cell therapies.
Conclusions: Firefighters indicated they were largely willing to participate in a stem cell clinical trial but also indicated a lack of knowledge upon which to make a decision. Public education of the role of stem cells in STSG will be increasingly important as clinical trials are developed.
Huang X, Qin X, Li M, Li Y, Shen L, Jin G Nurs Open. 2023; 10(8):5293-5305.
PMID: 37431277 PMC: 10333896. DOI: 10.1002/nop2.1767.
Patient and public perspectives on cell and gene therapies: a systematic review.
Aiyegbusi O, Macpherson K, Elston L, Myles S, Washington J, Sungum N Nat Commun. 2020; 11(1):6265.
PMID: 33293538 PMC: 7722871. DOI: 10.1038/s41467-020-20096-1.
Li Y, Xia W, der Merwe L, Dai W, Lin C Stem Cell Res Ther. 2020; 11(1):322.
PMID: 32727568 PMC: 7389817. DOI: 10.1186/s13287-020-01839-9.
Levenberg K, Proctor D, Maman S, Luck J, Miller A, Aziz F SAGE Open Med. 2020; 8:2050312120930915.
PMID: 32587692 PMC: 7294489. DOI: 10.1177/2050312120930915.
Bachhuber M, Arnsten J, Starrels J, Cunningham C Cannabis Cannabinoid Res. 2018; 3(1):45-53.
PMID: 29607410 PMC: 5870058. DOI: 10.1089/can.2017.0051.